These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7985331)

  • 21. Practical Molecular Testing in a Clinical Genitourinary Service.
    Magers MJ; Cheng L
    Arch Pathol Lab Med; 2020 Mar; 144(3):277-289. PubMed ID: 31373513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial observations and problems with in vitro predictive assay in genitourinary malignancies.
    Zabbo A; Montie JE; Budd GT; Livingston RB
    Urology; 1984 Apr; 23(4):370-3. PubMed ID: 6538711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of vinblastine on DNA parameters and multidrug resistance in renal cell carcinoma in vitro.
    Domagk D; Blüthner-Hässler C; Kugler A; Kallerhoff M; Ringert RH
    Urol Res; 1998; 26(2):123-7. PubMed ID: 9631945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum].
    Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of urologic metastases].
    Zanoni F; Piva L; Milani A; Salvioni R; Faustini M; Nicolai N; Mangiarotti B; Pizzocaro G
    Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):37-43. PubMed ID: 1570524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemotherapy of urologic cancer.
    Carter SK; Wasserman TH
    Cancer; 1975 Aug; 36(2):729-47. PubMed ID: 125624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of advanced genitourinary tumors.
    Pietrantonio F; Biondani P; Verzoni E; Procopio G
    Tumori; 2012; 98(2):264-6. PubMed ID: 22677995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genitourinary malignancy.
    Haas N; Hudes GR
    Cancer Chemother Biol Response Modif; 1997; 17():504-35. PubMed ID: 9551229
    [No Abstract]   [Full Text] [Related]  

  • 30. Infectious complications of combination anticancer chemotherapy for urogenital cancers.
    Matsumoto T; Takahashi K; Tanaka M; Kumazawa J
    Int Urol Nephrol; 1999; 31(1):7-14. PubMed ID: 10408296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of uroepithelial tumors.
    Goldstein G
    Prog Clin Biol Res; 1978; 25():105-15. PubMed ID: 366625
    [No Abstract]   [Full Text] [Related]  

  • 32. Circadian chemotherapy for gynecological and genitourinary cancers.
    Kobayashi M; Wood PA; Hrushesky WJ
    Chronobiol Int; 2002 Jan; 19(1):237-51. PubMed ID: 11962679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon alpha2b differentially affects proliferation of two human renal cell carcinoma cell lines differing in the P-glycoprotein-associated multidrug-resistant phenotype.
    Frank MH; Pomer S
    J Cancer Res Clin Oncol; 1999; 125(2):117-20. PubMed ID: 10190320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of Peptichemio in neoplasms of the urogenital system].
    Aliffi E; De Grande G
    Minerva Urol; 1976 SEP-OCT; 28(5):247-52. PubMed ID: 1004464
    [No Abstract]   [Full Text] [Related]  

  • 35. New perspectives in advanced genitourinary malignancies.
    Biondani P; Procopio G; Pietrantonio F; de Braud F; Verzoni E
    Tumori; 2012; 98(2):267-9. PubMed ID: 22677996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDR1 gene expression in solid tumours.
    Goldstein LJ
    Eur J Cancer; 1996 Jun; 32A(6):1039-50. PubMed ID: 8763346
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
    Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current concepts in genitourinary oncology: a multidisciplinary approach.
    Rubin P
    J Urol; 1971 Sep; 106(3):315-38. PubMed ID: 5107052
    [No Abstract]   [Full Text] [Related]  

  • 39. Childhood urogenital sarcoma.
    Weissman MJ; Gaeta JF; Albert DJ
    J Surg Oncol; 1972; 4(2):109-16. PubMed ID: 5064186
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical studies of bestatin on genitourinary cancer].
    Ichikawa T; Hirokawa I; Ishihara Y
    Jpn J Antibiot; 1985 Jan; 38(1):166-78. PubMed ID: 3989976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.